What does the evidence say about Vitamin B6 PMS Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Vitamin B6 PMS Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - The quality of the selected articles was assessed utilizing the Cochrane Risk of Bias assessment checklist. [Sharifipour F (2025); evidence level 1] - The combined analysis of these three studies indicated that there were no differences between the two groups of vitamins B6 and placebo in a reduction of pain intensity (SMD = -3.57, 95% CI: -9.15 to 2.01; very low certainty of evidence), with high heterogeneity among the studies (I² = 99.56%). [Sharifipour F (2025); evidence level 1] - Conclusion This meta-analysis did not demonstrate a statistically significant effect of vitamin B6 on mastalgia severity. [Sharifipour F (2025); evidence level 1] - Background Mastalgia represents the most frequent complaint among women at some point during their lives that can have a profound impact on both the physical and mental well-being of individuals affected by this condition. [Sharifipour F (2025); evidence level 1] - Some evidence suggests that women with Rh-negative blood type may have a higher likelihood of developing premenstrual symptoms, although mechanistic explanations remain speculative and findings are not yet consistent across studies. [Martire Francesco Giuseppe (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.